These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 9433492

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT, Sugiura Y, Laug WE, Sun B, Garcia A, DeClerck YA.
    J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
    [Abstract] [Full Text] [Related]

  • 4. Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells.
    Miyagi E, Yasumitsu H, Hirahara F, Minaguchi H, Koshikawa N, Miyazaki K, Umeda M.
    Jpn J Cancer Res; 1995 Jun; 86(6):568-76. PubMed ID: 7622422
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Proteases and their inhibitors in human brain tumours: a review.
    Rooprai HK, McCormick D.
    Anticancer Res; 1997 Jun; 17(6B):4151-62. PubMed ID: 9428349
    [Abstract] [Full Text] [Related]

  • 7. Different roles for plasminogen activators and metalloproteinases in melanoma metastasis.
    Mueller BM.
    Curr Top Microbiol Immunol; 1996 Jun; 213 ( Pt 1)():65-80. PubMed ID: 8814995
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proteases associated with invadopodia, and their role in degradation of extracellular matrix.
    Chen WT.
    Enzyme Protein; 1996 Jun; 49(1-3):59-71. PubMed ID: 8796997
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases.
    Wang Q, Shaltiel S.
    BMC Biochem; 2003 Jul 08; 4():5. PubMed ID: 12848892
    [Abstract] [Full Text] [Related]

  • 15. [Cellular proteases and invasion].
    Roessner A, Krüger S, Kido A.
    Verh Dtsch Ges Pathol; 2000 Jul 08; 84():69-76. PubMed ID: 11217451
    [Abstract] [Full Text] [Related]

  • 16. Proteases and cancer invasion: from belief to certainty. AACR meeting on proteases and protease inhibitors in cancer, Nyborg, Denmark, 14-18 June 1998.
    Blasi F, Stoppelli MP.
    Biochim Biophys Acta; 1999 Jan 29; 1423(1):R35-44. PubMed ID: 9989212
    [No Abstract] [Full Text] [Related]

  • 17. Modulation of biological phenotypes for tumor growth and metastasis by target-specific biological inhibitors in gastric cancer.
    Rha SY, Noh SH, Kim TS, Yoo NC, Roh JK, Min JS, Kim BS.
    Int J Mol Med; 1999 Aug 29; 4(2):203-12. PubMed ID: 10402490
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.